VCAM1 and Bell's palsy: Thus, CCL19, SELL and VCAM-1 may not be sequential activation of a single pathway, but rather synergize through different mechanisms such as chemotaxis, adhesion and barrier modulation to drive the inflammatory response and pathological injury in Bell’s palsy.